The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC 157 The Niche BPC 157 Banned: Key Facts on the Latest FDA Decision